Whitehawk therapeutics to participate in the td cowen 6th annual oncology innovation summit

Morristown, n.j. , may 21, 2025 /prnewswire/ -- whitehawk therapeutics, inc. (nasdaq: whwk), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved adc cancer treatments, announced today the company's president and ceo, dave lennon, phd, will participate in a fireside chat at the td cowen 6th annual oncology innovation summit: insights for asco & eha, on may 28, 2025, at 2:30 pm et.
COWN Ratings Summary
COWN Quant Ranking